Virtus Biotech ETF · $132M$20,310
BBPBBP vsARKGARKGARK Genomic Revolution ETF · $2.2B$6,586
$10,000 five years ago, dividends reinvested · they hold 2.1% in common
BBPMeasureARKG
Returns · dividends reinvested
+29.5%Year to dateJan 1 → Nov 3+70.9%
+38.7%1 yearTotal return+59.0%
+31.7%3 years · per year$10,000 became $22,842 · $22,262+30.6%
+15.2%5 years · per year$10,000 became $20,310 · $6,586−8.0%
Cost and income
0.34%Expense ratio$34 · $75 a year on $10k · lower is better0.75%
0.00%Trailing 12-mo yield$0 · $0 a year on $10k0.00%
Risk · past year
−9.4%Worst dropSmaller is better−27.5%
26.5%VolatilityLower is calmer45.8%
BBPARKG Winner of the row, in its colourEach row: the bigger of the two fills its side
5–2BBP wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns